title: Morphine-induced MOR-1X and ASF/SF2 Expressions Are Independent of Transcriptional Regulation: Implications for MOR-1X Signaling.
abstract: Recently, multiple μ-opioid receptor (MOR) isoforms have been identified that originate from a single gene, OPRM1; however, both their regulation and their functional significance are poorly characterized. The objectives of this study were to decipher, first, the regulation of alternatively spliced μ-opioid receptor isoforms and the spliceosome components that determine splicing specificity and, second, the signaling pathways utilized by particular isoforms both constitutively and following agonist binding. Our studies demonstrated that the expression of a particular splice variant, MOR-1X, was up-regulated by morphine, and this coincided with an increase in the essential splicing factor ASF/SF2. Structural comparison of this isoform to the prototypical variant MOR-1 revealed that the unique distal portion of the C-terminal domain contains additional phosphorylation sites, whereas functional comparison found distinct signaling differences, particularly in the ERK and p90 RSK pathways. Additionally, MOR-1X expression significantly reduced Bax expression and mitochondrial dehydrogenase activity, suggesting a unique functional consequence for MOR-1X specific signaling. Collectively, these findings suggest that alternative splicing of the MOR is altered by exogenous opioids, such as morphine, and that individual isoforms, such as MOR-1X, mediate unique signal transduction with distinct functional consequence. Furthermore, we have identified for the first time a potential mechanism that involves the essential splicing factor ASF/SF2 through which morphine regulates splicing specificity of the MOR encoding gene, OPRM1.
authors.affiliation: Department of Neuroscience and Center for Neurovirology, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania.
authors.forename: Patrick M
authors.initials: PM
authors.lastname: Regan
authors.affiliation: Department of Neuroscience and Center for Neurovirology, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania.
authors.forename: Ilker K
authors.initials: IK
authors.lastname: Sariyer
authors.affiliation: Department of Neuroscience and Center for Neurovirology, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania.
authors.forename: T Dianne
authors.initials: TD
authors.lastname: Langford
authors.affiliation: Department of Neuroscience and Center for Neurovirology, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania.
authors.forename: Prasun K
authors.initials: PK
authors.lastname: Datta
authors.affiliation: Department of Neuroscience and Center for Neurovirology, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania.
authors.forename: Kamel
authors.initials: K
authors.lastname: Khalili
mesh_terms: D017398:Alternative Splicing / Q000235:genetics; D005786:Gene Expression Regulation / Q000187:drug effects; D006801:Humans; D009020:Morphine / Q000008:administration & dosage; D020033:Protein Isoforms / Q000235:genetics; D017450:Receptors, Opioid, mu / Q000096:biosynthesis / Q000235:genetics*; D000068103:Serine-Arginine Splicing Factors / Q000235:genetics*; D015398:Signal Transduction / Q000187:drug effects; D014158:Transcription, Genetic
chemical_list: C485764:OPRM1 protein, human; D020033:Protein Isoforms; D017450:Receptors, Opioid, mu; C000595779:SRSF1 protein, human; D000068103:Serine-Arginine Splicing Factors; D009020:Morphine